|
|
|
|
Breast Lumpectomy Procedures News
|
|
|
|
|
|
|
All Recent Breast Lumpectomy Procedures News |
|
|
|
|
Breast MRI After Conservation Therapy: Usual Findings in Routine Follow-Up Examinations
CONCLUSION. After a patient has undergone BCT, MRI shows changes in
both breasts. Although the changes in our study population were greatest in
the treated breast, parenchymal enhancement and cystic alteration decrease
bilaterally indicating a systemic influence. Edematous changes, seroma, focal
enhancement, and skin thickening were seen only in the treated breast. All
posttreatment MRI findings decrease progressively, and all may persist.
Lumpectomy site enhancement is most persistent in women with fat necrosis. (Source: American Journal of Roentgenology)...
POSTED 08/20/2010 at 01:02 PM --
|
Breast cancer in young women
Abstract Recent evidence suggests that the incidence of local breast tumor recurrences and failures may be substantially lower than
previously thought due to the widespread use of systemic adjuvant therapy and loco-regional treatments. Surgery is a fundamental
aspect of the management of breast cancer, and the mainstay of loco-regional treatment. In younger women, the choice of surgical
approach (radical mastectomy vs lumpectomy) is influenced by tumor size, multicentricity, breast volume, genetic predisposition
to the disease, and the patientâs wishes, because breast resections can have a major impact on the patientâs quality of life.
Currently, adjuvant radiotherapy is recommended for all women following breast surgery. It significantly reduces the rate
of relapse an......
POSTED 08/13/2010 at 12:41 PM --
|
Tools for consensus analysis of experts' contours for radiotherapy structure definitions.
CONCLUSIONS: Using the consensus software tool incorporating STAPLE estimates provided the ability to create contours similar to the ones generated by expert physicians.
PMID: 20708285 [PubMed - as supplied by publisher] (Source: Radiotherapy and Oncology : journal of the European Society for Therapeutic Radiology and Oncology)...
POSTED 08/10/2010 at 06:00 PM --
|
Breast Reduction in the Irradiated Breast: Evidence for the Role of Breast Reduction at the Time of Lumpectomy
Abstract: Given the high incidence of breast cancer in our society, it is common to encounter patients with macromastia who desire breast reduction after breast-conserving therapy by lumpectomy and radiation. We hypothesize that radiation leads to a significant increase in postoperative complications after breast reduction. All patients with a history of unilateral breast lumpectomy and radiation who subsequently underwent bilateral breast reduction by a single surgeon from 2004 to 2008 were retrospectively reviewed. Outcomes including cellulitis, wound breakdown, seroma, and need for repeat operations were compared between the radiated and nonradiated breast. The Fisher's exact test was used for statistical analysis. Twelve patients (mean age, 57 years) underwent bilateral breast reductio......
POSTED 08/02/2010 at 06:00 PM --
|
Outcome after mastectomy for ipsilateral breast tumor recurrence after breast conserving surgery.
Authors: Beard HR, Cantrell EF, Russell GB, Howard-McNatt M, Shen P, Levine EA
Ipsilateral breast tumor recurrence (IBTR) is a risk after breast conserving surgery, and is traditionally treated with mastectomy. Given the limited literature on outcome after mastectomy for IBTR, we evaluated our long-term data for this group. A retrospective review was conducted using a database of 2101 breast cancer patients at a single institution. Fifty-nine patients underwent breast conserving surgery and experienced an IBTR. Exclusion criteria included repeat lumpectomy or metastatic disease before mastectomy. Patients presented with invasive ductal (58%), invasive lobular (7%), other invasive (11%), or ductal carcinoma in situ (24%). Initial tumors were Tis (24%), T1 (42%), T2 (20%), T3 (2%), or no......
POSTED 07/31/2010 at 06:00 PM --
|
Radiation After Lumpectomy Can Be Omitted for Certain Women With Breast Cancer [Medical News & Perspectives]
(Source: JAMA)...
POSTED 07/27/2010 at 02:51 PM --
|
Reduction mammaplasty as a secondary therapy option for chronic pain after lumpectomy in the breast: a case report
Abstract Chronic breast pain after surgery can have a profoundly negative impact on the physical and psychosocial function of patients.
Treatment options are still in development, and no method hitherto described 100% pain relief. A 45-year-old woman suffering
from chronic pain following breast surgery, who underwent reduction mammaplasty that lead to 100% pain relief, is presented.
We suggest that mammaplasty could be a valuable treatment option in treating carefully selected patients with chronic breast
pain. To our knowledge, this is the first report of mammaplasty for the treatment of chronic breast pain following breast
surgery.
Content Type Journal ArticleCategory Case ReportDOI 10.1007/s00238-010-0480-yAuthors
Fercan Kömürcü, KA Rudolfstiftung Department of......
POSTED 07/26/2010 at 05:08 PM --
|
Dosimetry evaluation of SAVI-based HDR brachytherapy for partial breast irradiation
Sivasubramanian R Manoharan, R Rodney Rodriguez, Vidya S Bobba, Mukka ChandrashekarJournal of Medical Physics 2010 35(3):131-136Accelerated partial breast irradiation (APBI) with high dose rate (HDR) brachytherapy offers an excellent compact course of radiation due to its limited number of fractions for early-stage carcinoma of breast. One of the recent devices is SAVI (strut-adjusted volume implant), which has 6, 8 or 10 peripheral source channels with one center channel. Each channel can be differentially loaded. This paper focuses on the treatment planning, dosimetry and quality assurance aspects of HDR brachytherapy implant with GammaMed Plus HDR afterloader unit. The accelerated PBI balloon devices normally inflate above 35 cc range, and hence these balloon type devices cannot be acco......
POSTED 07/26/2010 at 02:39 AM --
|
Metaplastic Breast Cancer: To Radiate or Not to Radiate?
Conclusions Our findings support the use of RT for patients with MBC following lumpectomy or mastectomy. These retrospective findings
should be confirmed in a prospective clinical trial.
Content Type Journal ArticleCategory Breast OncologyDOI 10.1245/s10434-010-1198-6Authors
Warren H. Tseng, University of California Davis Division of Surgical Oncology, Department of Surgery Sacramento CA USASteve R. Martinez, University of California Davis Division of Surgical Oncology, Department of Surgery Sacramento CA USA
Journal Annals of Surgical OncologyOnline ISSN 1534-4681Print ISSN 1068-9265 (Source: Annals of Surgical Oncology)...
POSTED 06/29/2010 at 09:08 AM --
|
Update on DCIS Outcomes from the American Society of Breast Surgeons Accelerated Partial Breast Irradiation Registry Trial
Conclusions During an extended follow-up period, APBI delivered via MammoSite continued to be well tolerated for patients with DCIS. Use
of this device may make lumpectomy possible for patients who would otherwise choose mastectomy because of barriers associated
with standard radiation therapy.
Content Type Journal ArticleCategory Breast OncologyDOI 10.1245/s10434-010-1192-zAuthors
Jacqueline S. Jeruss, Northwestern University Feinberg School of Medicine Department of Surgery Chicago IL USAHenry M. Kuerer, University of Texas M. D. Anderson Cancer Center Department of Surgical Oncology Houston TX USAPeter D. Beitsch, Dallas Breast Center Department of Surgery Dallas TX USAFrank A. Vicini, William Beaumont Hospital Department of Radiation Oncology Royal Oak MI USAMar......
POSTED 06/25/2010 at 11:59 AM --
|
Clinicopathologic Presentation of Asian-Indian American (AIA) Women with Stage 0, I & II Breast Cancer
Abstract Although numerous studies have looked at cancer incidence and survival in Asian Indian-American (AIA) patients, there is a
paucity of data regarding clinicopathologic presentation of cancer in this ethnically diverse population. After receiving
IRB approval, AIA patients of Indian and Pakistani descent who presented with Stage 0, I, & II breast cancer to our facility
were identified. Charts were extracted for clinical and pathologic variables in addition to outcomes data. Standard statistical
analyses were performed using SAS (v 9.1). The population (n = 50) consisted of 86% Indian (n = 43) and 14% Pakistani (n = 7). The median age at diagnosis was 52 (range 25â79). Sixty-three percent of tumors were detected after discovery of a
pal......
POSTED 06/20/2010 at 06:14 PM --
|
Prone versus supine positioning for whole and partial-breast radiotherapy: A comparison of non-target tissue dosimetry
Conclusions: In the context of tangential-field WBI and PBI, prone positioning is likely to benefit left-breast-affected women of larger breast volume, but to be detrimental in left-breast-affected women of smaller breast volume. Right-breast-affected women are likely to benefit from prone positioning regardless of breast volume. (Source: Radiotherapy and Oncology)...
POSTED 06/20/2010 at 06:00 PM --
|
Size of boost field may need re-evaluating in breast conservation therapy
Patients who receive chemotherapy before whole-breast radiation receive radiotherapy to a smaller volume of tissue than those who do not due to contraction of the lumpectomy cavity, research suggests. (Source: MedWire News - Oncology)...
POSTED 06/14/2010 at 07:00 PM --
|
Size of boost field may need re-evaluating in breast conservation therapy
Patients who receive chemotherapy before whole-breast radiation receive radiotherapy to a smaller volume of tissue than those who do not due to contraction of the lumpectomy cavity, research suggests. (Source: MedWire News - Breast Cancer)...
POSTED 06/14/2010 at 07:00 PM --
|
Clinical Series of Oncoplastic Mastopexy to Optimize Cosmesis of Large-Volume Resections for Breast Conservation
Conclusions Oncoplastic mastopexy allows the surgeon to address large tumors or tumors in cosmetically difficult sites adequately for
breast conservation. Careful margin marking and re-excision of close or positive margins is still often feasible to achieve
adequate negative margin with acceptable cosmesis in spite of the large initial volumes of resection.
Content Type Journal ArticleCategory Breast OncologyDOI 10.1245/s10434-010-1140-yAuthors
J. Bong, Institute for Breast Health, The University of Oklahoma Health Sciences Center Division of Surgical Oncology, Department of Surgery Oklahoma City OK USAJ. Parker, Institute for Breast Health, The University of Oklahoma Health Sciences Center Division of Surgical Oncology, Department of Surgery Oklahoma City OK USAR. ......
POSTED 06/14/2010 at 08:47 AM --
|
The Effect of Simultaneous Peripheral Excision in Breast Conservation upon Margin Status
Conclusions Smaller tumor size, lack of EIC, and greater numbers of simultaneous PSs excised decrease the likelihood of positive margins,
despite a lack of correlation between segment numbers and excised volume. These findings suggest that excision of simultaneous
PSs may assist in achieving negative margins, in part, because of avoidance of pathologic artifact.
Content Type Journal ArticleCategory Breast OncologyDOI 10.1245/s10434-010-1123-zAuthors
Roshani R. Patel, Fox Chase Cancer Center Department of Surgical Oncology Philadelphia PA USATianyu Li, Fox Chase Cancer Center Department of Biostatistics Philadelphia PA USAEric A. Ross, Fox Chase Cancer Center Department of Biostatistics Philadelphia PA USALinda Sesa, Fox Chase Cancer Center Department of Surgical Onc......
POSTED 06/14/2010 at 08:46 AM --
|
Addition of Radiation to Tamoxifen After Lumpectomy Provides Minimal Benefit in Elderly Early-Stage Breast Cancer Patients
Capsule Summary - Updated analysis of CALGB 9343 study at median follow-up of 12 months demonstrates 7% absolute reduction in rate of ipsilateral breast recurrence associated with addition of radiation to tamoxifen after lumpectomy in patients aged 70 years or older but no survival or breast preservation benefit. (Source: Clinical Care Options Oncology - Breast Cancer)...
POSTED 06/09/2010 at 07:00 PM --
|
In Postmenopausal Women With Highly ER-Positive Breast Cancer, Neoadjuvant Endocrine Therapy Associated With Conversion From Mastectomy to Lumpectomy in 51% of Cases
Capsule Summary - No clinically significant efficacy or safety differences were observed between exemestane, letrozole, and anastrozole in this randomized phase II trial. (Source: Clinical Care Options Oncology - Breast Cancer)...
POSTED 06/08/2010 at 07:00 PM --
|
In Postmenopausal Women With Highly ER-Positive Breast Cancer, Neoadjuvant Endocrine Therapy Associated With Conversion From Mastectomy to Lumpectomy in 51% of Cases
Capsule Summary - No clinically significant efficacy or safety differences were observed between exemestane, letrozole, and anastrozole in this randomized phase II trial. (Source: Clinical Care Options Oncology - Breast Cancer)...
POSTED 06/08/2010 at 07:00 PM --
|
Findings May Alter Care for Early Breast Cancer
One study questioned the need for lumpectomies and another challenged standard radiation therapy, finding a single-dose treatment just as effective. (Source: NYT Health)...
POSTED 06/07/2010 at 04:19 PM --
|
|
|
|
|
|
 |
|
|
|
|
|
IMPORTANT NOTICE:
The information provided on this site is intended for your general knowledge only and is not a substitute for professional
medical advice or treatment for specific medical conditions. You should not use this information to diagnose or treat a health problem or disease without consulting with a
qualified healthcare provider. Please consult your healthcare provider with any questions or concerns you may have regarding your condition.
|
|
|
|
|
|
|
|
Featured Product! |
 |
|
Arthrit-Eze |
|
Arthrit-Eze is the most advanced
formula on the market today |
|
It offers potential relief and
rejuvenation for all forms of arthritis, safely, naturally and without side
effects!
NO PRESCRIPTION REQUIRED! |
|
CLICK HERE
for more info... |
|
|
